申请人:NOVARTIS AG
公开号:US20170369473A1
公开(公告)日:2017-12-28
The invention relates to heterocyclic angiotensin II type 2 (AT
2
) receptor antagonists of formula (I), and pharmaceutically acceptable salts thereof, ((I) in which all of the variables are as defined in the specification, pharmaceutical compositions thereof,combinations thereof, and their use as medic-aments, particularly for the treatment of neuropathic or inflammatory pain.